It is hypothesized that obesity causes metabolic abnormalities such as hypertension, glucose metabolic disorders, and dyslipidemia due to uncontrolled FFA release from adipose tissue and decreased insulin sensitivity. This evidence concerns the gene INS and Hypertension.